Können Biologika bei rheumatoider Arthritis nach Erreichen einer Remission abgesetzt werden? Pro

rheumatoide Arthritis - Biologika - Remission - Erhaltungstherapie

rheumatoid arthritis - biologicals - remission - maintenance therapy

Literatur

• 1 Aletaha D, Neogi T, Silman A J. et al . 2010 Rheumatoid arthritis classification criteria: an American College of rheumatology/European league against rheumatism collaborative initiative.  Arthritis Rheum. 2010;  62 2569-2581
• 2 Emery P, Smolen J S, Kavanaugh A. et al . Maintenance of biologic-free disease control in early rheumatoid arthritis patients after induction of low disease activity with adalimumab plus methotrexate.  Ann Rheum Dis. 2011;  70 (Suppl 3) 262
• 3 Klarenbeek N B, Güler-Yüksel M, Kooij. et al . Clinical outcomes of four different treatment strategies in patients with recent-onset rheumatoid arthritis: 5 years resukts of the BeSt Study.  Ann Rheum Dis. 2008;  67 (Suppl II) 187
• 4 Smolen J S, Landewe R, Breedveld F C. et al . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.  Ann Rheum Dis. 2010;  69 964-975
• 5 Tanaka Y, Takeuchi T, Mimori T. et al . Discontinuation of infliximab therapy is possible after acquiring remission in patients with rheumatoid arthritis (RA): First report on RRR (Remission inductionby Remicade in RA) study.  Ann Rheum Dis. 2009;  68 (Suppl 3) 120